Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sakurasaku Plus CoTSE:7097 72 Debt-to-Equity is 0.86 as of Jan. 2026, which is 26% below its 10-year median of 1.16. GuruFocus rates TSE:7097 with a GF Score™ of 72/100 and a GF Value™ of 円1,615.95 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 563 Healthcare Providers & Services companies, Sakurasaku Plus Co ranks worse than 69.45% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Sakurasaku Plus Co's Debt-to-Equity or its related term are showing as below:
TSE:7097'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.63 Med: 1.16 Max: 3.07
Current: 0.85
During the past 8 years, the highest Debt-to-Equity Ratio of Sakurasaku Plus Co was 3.07. The lowest was 0.63. And the median was 1.16.
TSE:7097's Debt-to-Equity is ranked worse than 69.45% of 563
companies
in the Healthcare Providers & Services industry
Industry Median: 0.43
vs TSE:7097: 0.85
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Sakurasaku Plus Co Debt-to-Equity Related Terms
Sakurasaku Plus Co Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Sakurasaku Plus Co's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7097 vs HCA, THC, EHC: Debt-to-Equity Comparison
For the Medical Care Facilities subindustry, Sakurasaku Plus Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sakurasaku Plus Co Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sakurasaku Plus Co's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Sakurasaku Plus Co's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sakurasaku Plus Co (TSE:7097) has a Debt-to-Equity of 0.86 as of Jan. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Sakurasaku Plus Co and its competitors. This is 26% below median its historical median of 1.16. Over the past decade, Sakurasaku Plus Co's Debt-to-Equity has ranged from 0.63 to 3.07. According to the industry distribution chart, Sakurasaku Plus Co ranks #391 out of 563 companies in the Healthcare Providers & Services industry, placing it in the top 69.4%.
Is Sakurasaku Plus Co's Debt-to-Equity too high?
Sakurasaku Plus Co's current Debt-to-Equity of 0.86 is 26% below median its 10-year median of 1.16. Over the past 10 years, this metric has ranged from a low of 0.63 to a high of 3.07. The Healthcare Providers & Services industry median Debt-to-Equity is 0.43. Sakurasaku Plus Co's value of 0.86 is 100% above this industry median. Based on the distribution chart, Sakurasaku Plus Co ranks #391 out of 563 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Sakurasaku Plus Co has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sakurasaku Plus Co's Debt-to-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Sakurasaku Plus Co ranks #391 out of 563 companies for Debt-to-Equity. This places Sakurasaku Plus Co in the lower half of its industry. The industry median Debt-to-Equity is 0.43. Sakurasaku Plus Co's value of 0.86 is 100% above this benchmark. Historically, Sakurasaku Plus Co's own Debt-to-Equity has ranged from 0.63 to 3.07 over the past decade. While the company's 10-year median is 1.16 vs. the industry median of 0.43, Sakurasaku Plus Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.43, based on 563 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sakurasaku Plus Co's current Debt-to-Equity of 0.86 is 100% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Sakurasaku Plus Co and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sakurasaku Plus Co's current Debt-to-Equity is 0.86, which is 26% below median its own 10-year median of 1.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sakurasaku Plus Co stock overvalued right now?
Based on GuruFocus' analysis, Sakurasaku Plus Co (TSE:7097) is currently considered Significantly Overvalued. The stock's GF Value™ is 円1,615.95, compared to a current price of 円2,750.00 — trading 70.2% above its estimated fair value. The current Debt-to-Equity is 0.86, which is 26% below median its 10-year median of 1.16 and 100% above the Healthcare Providers & Services industry median of 0.43. Sakurasaku Plus Co's overall GF Score™ is 72/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Sakurasaku Plus Co (TSE:7097), the current Debt-to-Equity is 0.86 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sakurasaku Plus Co (TSE:7097) Overvalued in 2026?
Based on GuruFocus' analysis, Sakurasaku Plus Co stock appears to be overvalued.
The current stock price of 円2,750.00 is trading 70.2% above its estimated GF Value™ of 円1,615.95.
GuruFocus considers Sakurasaku Plus Co to be Significantly Overvalued.
Key valuation signals for TSE:7097:
Debt-to-Equity: 0.86 (26% below median its 10-year median of 1.16)
GF Value™: 円1,615.95 vs. price of 円2,750.00 (70.2% above fair value)
Industry Position: 100% above the Healthcare Providers & Services median (#391 of 563)
No single metric tells the full story. See the TSE:7097 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sakurasaku Plus Co Ltd is engaged in the operation and use of childcare daycare centers. The company also provides real estate brokerage and management services. The Group operates in a single segment, the children and childcare support business.
72GF Score
Get the complete analysis for TSE:7097
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7097 has been successfully added to your 
